Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Børre, Fevang"'
Autor:
Hedda Hoel, Tuva Børresdatter Dahl, Kuan Yang, Linda Gail Skeie, Annika Elisabet Michelsen, Thor Ueland, Jan Kristian Damås, Anne Ma Dyrhol-Riise, Børre Fevang, Arne Yndestad, Pål Aukrust, Marius Trøseid, Øystein Sandanger
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7141 (2024)
Antiretroviral treatment (ART) has converted HIV from a lethal disease to a chronic condition, yet co-morbidities persist. Incomplete immune recovery and chronic immune activation, especially in the gut mucosa, contribute to these complications. Infl
Externí odkaz:
https://doaj.org/article/2082d071afd1473c96cbdea9fab7a235
Autor:
Silje F. Jorgensen, Magnhild E. Macpherson, Tonje Skarpengland, Rolf K. Berge, Børre Fevang, Bente Halvorsen, Pål Aukrust
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The relationship between metabolic and inflammatory pathways play a pathogenic role in various cardiometabolic disorders and is potentially also involved in the pathogenesis of other disorders such as cancer, autoimmunity and infectious diseases. Com
Externí odkaz:
https://doaj.org/article/d3d6e2966bfc4f48b82397215aa3315a
Autor:
Heba M. Bintalib, Annick van de Ven, Joseph Jacob, Jesper Rømhild Davidsen, Børre Fevang, Leif G. Hanitsch, Marion Malphettes, Joris van Montfrans, Paul J. Maglione, Cinzia Milito, John Routes, Klaus Warnatz, John R. Hurst
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionCommon variable immunodeficiency related interstitial lung disease (CVID-ILD, also referred to as GLILD) is generally considered a manifestation of systemic immune dysregulation occurring in up to 20% of people with CVID. There is a lack
Externí odkaz:
https://doaj.org/article/d8800fa1ddb14578bcf8cfe3598dc115
Autor:
Ragnhild Øye Løken, Børre Fevang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
COVID-19 has shed light on the role of cellular immunity in the absence of humoral response in different patient groups. Common variable immunodeficiency (CVID) is characterized by impaired humoral immunity but also an underlying T-cell dysregulation
Externí odkaz:
https://doaj.org/article/b472dd544996431084667f0944e83275
Autor:
Arne Søraas, Gunnveig Grødeland, Beathe Kiland Granerud, Thor Ueland, Andreas Lind, Børre Fevang, Sarah L. Murphy, Camilla Huse, Anders Benteson Nygaard, Anne Katrine Steffensen, Huda al-Baldawi, Mona Holberg-Petersen, Lise Lima Andresen, Camilla Ågnes, Trine Ranheim, Ylva Schanke, Mette Istre, John Arne Dahl, Adity Chopra, Susanne Dudman, Mari Kaarbø, Jan Terje Andersen, Eline Benno Vaage, Trung The Tran, John Torgils Vaage, Annika E. Michelsen, Fredrik Müller, Pål Aukrust, Bente Halvorsen, Tuva B. Dahl, Jan Cato Holter, Fridtjof Lund-Johansen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundResults showing that sera from double vaccinated individuals have minimal neutralizing activity against Omicron have been interpreted as indicating the need for a third vaccine dose for protection. However, there is little information about
Externí odkaz:
https://doaj.org/article/b48aae54e3e14b67ad888efba97122e0
Autor:
Børre Fevang, Vegard Bruun Bratholm Wyller, Tom Eirik Mollnes, Maria Pedersen, Tarjei Tørre Asprusten, Annika Michelsen, Thor Ueland, Kari Otterdal
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundEpstein-Barr virus (EBV) causes infectious mononucleosis (IM) that can lead to chronic fatigue syndrome. The CEBA-project (Chronic fatigue following acute EBV infection in Adolescents) has followed 200 patients with IM and here we present a
Externí odkaz:
https://doaj.org/article/6eb7cefaa4a04fc18735b43a8a906eb2
Autor:
John R. Hurst, S. Hamza Abbas, Heba M. Bintalib, Tiago M. Alfaro, Ulrich Baumann, Siobhan O. Burns, Alison Condliffe, Jesper R. Davidsen, Børre Fevang, Andrew R. Gennery, Filomeen Haerynck, Joseph Jacob, Stephen Jolles, Olivia Lamers, Anne Bergeron, Marion Malphettes, Véronique Meignin, Cinzia Milito, Tomas Milota, Martine Pergent, Antje Prasse, Isabella Quinti, Elisabetta Renzoni, Anna Sediva, Daiana Stolz, Bas Smits, Friedolin Strauss, Annick A.J.M. van de Ven, Joris van Montfrans, Klaus Warnatz
Publikováno v:
ERJ Open Research, Vol 7, Iss 4 (2021)
Externí odkaz:
https://doaj.org/article/7084a0aa8f714798a22a64d7160cde09
Autor:
Beathe K. Granerud, Thor Ueland, Andreas Lind, Arne Søraas, Børre Fevang, Anne Katrine Steffensen, Huda Al-Baldawi, Fridtjof Lund-Johansen, Pål Aukrust, Bente Halvorsen, Tuva B. Dahl, Susanne Dudman, Fredrik Müller, Jan Cato Holter
Publikováno v:
Viruses, Vol 14, Iss 11, p 2420 (2022)
The Omicron variant of SARS-CoV-2 spreads more easily than earlier variants, possibly as a result of a higher viral load in the upper respiratory tract and oral cavity. Hence, we investigated whether the Omicron variant generates a higher viral load
Externí odkaz:
https://doaj.org/article/87ca07ac80ec4a1e847a1728df3cf086
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/8ae9f39c38e1459481eefb5bf36d666e
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-5 (2019)
Abstract Objective Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of suspected adverse reactio
Externí odkaz:
https://doaj.org/article/ada57fd7681243eb983f58d280c0ea78